3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Neuroscience Letters

• Publication date

  2004-08-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NEULET.2004.05.075PMID 15308297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake.

  2004cited by this paper
• Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2004.

  2003cited by this paper
• An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA.

  2002cited by this paper
• Biochemical effects of the monoamine neurotoxins DSP‐4 and MDMA in specific brain regions of MAO‐B‐deficient mice

  2001cited by this paper
• 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

  2001cited by this paper
• Ascorbic acid prevents 3,4‐methylenedioxymethamphetamine (MDMA)‐induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5‐HT

  2001cited by this paper
• An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.

  1998cited by this paper
• Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

  1998cited by this paper
• Invited Review Free radicals and the pathobiology of brain dopamine systems

  1998cited by this paper
• Memory impairment in abstinent MDMA ("Ecstasy") users

  1998cited by this paper
• Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin.

  1998cited by this paper
• The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells

  1997cited by this paper
• A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative.

  1997cited by this paper
• In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p‐chloroamphetamine but not the degeneration following fenfluramine

  1997cited by this paper
• A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5‐HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy

  1997cited by this paper
• A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases.

  1997cited by this paper
• 2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations.

  1997cited by this paper
• Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.

  1996cited by this paper
• Carrier‐Mediated Release of Serotonin by 3,4‐Methylenedioxymethamphetamine: Implications for Serotonin‐Dopamine Interactions

  1996cited by this paper
• The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.

  1995cited by this paper
• Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan.

  1994cited by this paper
• Active [3H]-dopamine uptake by human lymphocytes: correlates with serotonin transporter activity.

  1994cited by this paper
• Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding.

  1993cited by this paper
• Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl] propane [(methylenedioxy)methamphetamine].

  1992cited by this paper
• Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR).

  1991cited by this paper
• Assessment of the role of α-methylapinine in the neurotoxicity of MDMA

  1991cited by this paper
• The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats.

  1991cited by this paper
• Assessment of the role of alpha-methylepinine in the neurotoxicity of MDMA.

  1991cited by this paper
• Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.

  1990cited by this paper
• Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis.

  1990cited by this paper
• Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.

  1988cited by this paper
• Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons.

  1988cited by this paper
• Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

  1987cited by this paper
• Use of MTT colorimetric assay to measure cell activation.

  1986cited by this paper
• Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.

  1986cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.

  1982cited by this paper
• Coupling of Dopamine Oxidation (Monoamine Oxidase Activity) to Glutathione Oxidation Via the Generation of Hydrogen Peroxide in Rat Brain Homogenates

  1981cited by this paper

• Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data

  2026cites this paper
• Ecstasy metabolites and monoamine neurotransmitters upshift the Na+/K+ ATPase activity in mouse brain synaptosomes

  2022cites this paper
• A Systematic Review of the MDMA Model to Address Social Impairment in Autism

  2021cites this paper
• Intramolecular charge transfer enhancing strategy based MAO-A specific two-photon fluorescent probes for glioma cell/tissue imaging.

  2021cites this paper
• Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine.

  2016cites this paper
• Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT

  2016cites this paper
• Light-Up Probes Based on Fluorogens with Aggregation-Induced Emission Characteristics for Monoamine Oxidase-A Activity Study in Solution and in Living Cells.

  2016cites this paper
• Effect of MDMA-Induced Axotomy on the Dorsal Raphe Forebrain Tract in Rats: An In Vivo Manganese-Enhanced Magnetic Resonance Imaging Study

  2015cites this paper
• Effects of long-term exposure of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on neuronal transmitter transport, brain immuno-regulatory systems and progression of experimental periodontitis in rats.

  2014cites this paper
• Nuevas drogas psicoestimulantes. Estudio farmacológico y neurotoxicológico de la metilona

  2014cites this paper
• 3,4-Methylenedioxymethamphetamine Induces Gene Expression Changes in Rats Related to Serotonergic and Dopaminergic Systems, But Not to Neurotoxicity

  2013cites this paper
• Interaction of mephedrone with dopamine and serotonin targets in rats.

  2012cites this paper
• Pro‐oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes

  2012cites this paper
• Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone

  2012cites this paper
• Drug Interactions between Common Illicit Drugs and Prescription Therapies

  2012cites this paper
• The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), methamphetamine and d-amphetamine

  2011cites this paper
• Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation

  2011cites this paper
• Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity.

  2011cites this paper
• Mice Lacking Multidrug Resistance Protein 1a Show Altered Dopaminergic Responses to Methylenedioxymethamphetamine (MDMA) in Striatum

  2010influential citation
• Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET

  2010cites this paper
• Monoamine Oxidases and Flavin-Containing Monooxygenases

  2010cites this paper
• Prenatal exposure to 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) has lasting consequences on neural development and behavior

  2010cites this paper
• Dual effects of 3, 4-methylenedioxymethamphetamine (ecstasy) on survival and apoptosis of primary hippocampal neurons*

  2009cites this paper
• Acetyl-L-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain.

  2009cites this paper
• On the Mechanisms Underlying 3,4-Methylenedioxymethamphetamine Toxicity: The Dilemma of the Chicken and the Egg

  2009cites this paper
• On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats.

  2008cites this paper
• Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons

  2008cites this paper
• Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria

  2007influential citation
• MDMA and Other “Club Drugs”

  2007cites this paper
• Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions

  2006cites this paper
• Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro

  2006cites this paper
• Possible Mechanisms of Neurodegeneration in Schizophrenia

  2006influential citation
• Performance Enhancement and Adverse Consequences of MDMA

  2006cites this paper
• Synthesis of Fluoro Analogues of 3,4‐(Methylenedioxy)amphetamine (MDA) and Its Derivatives

  2006cites this paper
• [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].

  2005cites this paper
• 3,4-metilenodioximetanfetamina ("éxtasis"): efectos emocionales y cognitivos a largo plazo y depleción serotoninérgica

  2005cites this paper